# Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

> **NCT04160000** · PHASE4 · RECRUITING · sponsor: **Electrophysiology Research Foundation** · enrollment: 360 (estimated)

## Conditions studied

- Atrial Fibrillation
- Heart Failure
- Diastolic Heart Failure

## Interventions

- **DEVICE:** Catheter ablation
- **DRUG:** Rate or Rhythm control antiarrhythmic drugs for atrial fibrillation
- **DEVICE:** Insertion of CardioMems Hemodynamic monitor
- **DRUG:** Empiric heart failure drug therapy

## Key facts

- **NCT ID:** NCT04160000
- **Lead sponsor:** Electrophysiology Research Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-26
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160000, "Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04160000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*